GoodRx and RxVantage Announce Strategic Relationship to Streamline Communications Between Providers and Manufacturers
May 17 2022 - 9:00AM
Business Wire
New features will be integrated into the GoodRx
platform and will allow providers to develop smarter connections
with manufacturers so they can get the information and resources
they need
GoodRx (Nasdaq: GDRX), a leading consumer-focused digital
healthcare platform, today announced a strategic relationship with
RxVantage that will enable healthcare providers to connect with
manufacturers on the GoodRx platform. Over 700,000 prescribers have
used GoodRx since June 2021, and GoodRx expects the new integration
from this strategic relationship will enable them to easily connect
with pharma representatives to ask questions about new therapies,
indications, side effects, patient assistance programs, and
clinical resources. By streamlining access to the valuable
educational resources and expertise that pharmaceutical companies
offer, the expected integration will be able to better serve
already time-constrained providers and help them provide better
resources to their patients.
The American Medical Association estimates providers spend a
significant amount of time per week trying to provide access to
medications for their patients. This adds to an already heavy
administrative burden and takes time away from providing hands-on
care. By integrating RxVantage into its provider platform, GoodRx
will be able to better address providers’ unique needs and help
them achieve better patient outcomes.
“Since the beginning, GoodRx has focused on helping physicians
and healthcare professionals help their patients, and with
RxVantage, we are adding new tools designed specifically for them,”
said Doug Hirsch, co-CEO and co-founder of GoodRx. “What makes our
platform unique is our ability to connect providers and
manufacturers in the right place at the right time, and in highly
relevant ways. Our planned integration with RxVantage will make
this offering even stronger - when providers come to GoodRx looking
for information on a certain drug, we will be able to seamlessly
connect them with the manufacturer to answer questions in a quick
and effective way.”
Providers consult GoodRx at the point of prescribing to help
their patients with access and affordability challenges. By
offering a way for these providers to connect with pharma
representatives, GoodRx will help create smarter connections
between stakeholders and reduce the administrative burden so
providers can put more focus on patient care. Expected to be
available within the GoodRx for Providers platform, the integrated
RxVantage features will provide a more customized experience and
equip providers with the tools they need to support their patients
throughout their healthcare journey.
“We’re excited to work with GoodRx to integrate our technology
into such a relevant platform. Working together, we will be able to
further empower users of GoodRx for Providers by directly
connecting them with the nearly 60,000 active manufacturer
representatives on RxVantage,” said Dan Gilman, co-founder and CEO
at RxVantage. “Our goal is to ensure every provider has the most
relevant educational information and resources needed to deliver
the best care to every patient, and we look forward to finding even
more ways to collaborate with GoodRx to achieve this goal.”
About GoodRx
GoodRx is a leading consumer-focused digital healthcare
platform. Our technology delivers strong savings, trusted
information and access to care to make healthcare affordable and
convenient for all Americans. Since 2011, we have helped consumers
save over $35 billion and are one of the most downloaded medical
apps over the past decade.
Forward-Looking Statements
This press release contains forward-looking statements within
the meaning of the Private Securities Litigation Reform Act of
1995. All statements contained in this press release that do not
relate to matters of historical fact should be considered
forward-looking statements, including without limitation statements
regarding the benefits of the strategic agreement between GoodRx
and RxVantage and any integration of RxVantage on the GoodRx
platform. These statements are neither promises nor guarantees, but
involve known and unknown risks, uncertainties and other important
factors that may cause our actual results, performance or
achievements to be materially different from any future results,
performance or achievements expressed or implied by the
forward-looking statements, including, but not limited to, risks
relating to our acquisition strategy, the integration of acquired
business and the important factors discussed under the caption
“Risk Factors” in GoodRx’s Annual Report on Form 10-K for the year
ended December 31, 2021, and our other filings with the SEC. These
factors could cause actual results to differ materially from those
indicated by the forward-looking statements made in this press
release. Any such forward-looking statements represent management’s
estimates as of the date of this press release. While we may elect
to update such forward-looking statements at some point in the
future, we disclaim any obligation to do so, even if subsequent
events cause our views to change.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20220517005345/en/
GoodRx Lauren Casparis lcasparis@goodrx.com
GoodRx (NASDAQ:GDRX)
Historical Stock Chart
From Mar 2024 to Apr 2024
GoodRx (NASDAQ:GDRX)
Historical Stock Chart
From Apr 2023 to Apr 2024